Physician

David Surprenant

According to 2025 Medicare claims, David Surprenant (NPI: 1265895932) practices dermatology in the Evansville, IN market, with the plurality of this provider's patient population coming from Vanderburgh, IN. This provider's primary affiliated billing organization is DEACONESS CLINC INC (NPI: 1992344071; TIN: 263083364) and primary practice location at 47708-1607. Surprenant is affiliated with the IHCI ACO LLC (ACO ID: A4931), participating under the MSSP model.

Surprenant's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 697 traditional Medicare patients, billed 2,274 HCPCS/CPT codes, and received $643,139 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 991 prescription claims across 763 beneficiaries totaling $8,471 in drug costs, led by Doxycycline Hyclate (Doxycycline Hyclate). Open Payments data shows 69 records totaling $1,198. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $6,637 to $643,139. In contrast, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $3,237 to $8,471. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	31	50	$6,637
2021	133	342	$86,256
2022	400	1,356	$380,859
2023	601	2,097	$610,581
2024	697	2,274	$643,139

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	13	31	$3,237
2017	99	191	$71,818
2018	74	147	$52,169
2019	27	51	$58,495
2020	130	168	$4,166
2021	180	239	$5,106
2022	347	457	$8,665
2023	609	779	$11,019
2024	763	991	$8,471

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17311	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks	580	713	$412
17312	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks	198	280	$299
13132	Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm	236	257	$173
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	87	87	$80
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	103	107	$65

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Doxycycline Hyclate	Doxycycline Hyclate	638	4,583	$4,205
Mupirocin	Mupirocin	216	3,309	$2,106
Fluorouracil	Fluorouracil	16	474	$1,162
Valacyclovir	Valacyclovir Hcl	58	297	$424
Gentamicin Sulfate	Gentamicin Sulfate	17	295	$388

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	69	$1,198	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David Surprenant?

Tedicare shows public-source Medicare data for David Surprenant (NPI 1265895932), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Surprenant have ACO affiliation data?

David Surprenant is shown with ACO affiliation data for IHCI ACO LLC (MSSP, ACO ID A4931).

What billing organization is linked to David Surprenant?

David Surprenant is linked to DEACONESS CLINC INC (billing NPI 1992344071) in the available physician profile data.

Does David Surprenant have Open Payments data?

David Surprenant has 69 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.